Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

CIK: 0001844645 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value ($000): $282,943 (100.0% shares, 0.0% debt)

Holdings (9)

— KARUNA THERAPEUTICS INC 36.9%

Value ($000) $104,312 Shares 852,708 Est. Cost $101.59 Unrealized —

— RALLYBIO CORP 14.1%

Value ($000) $39,930 Shares 2,271,311 Est. Cost $17.58 Unrealized —

PCVX VAXCYTE INC 12.6%

Value ($000) $35,656 Shares 1,405,421 Est. Cost $37.18 Unrealized -34.8%

— BOLT BIOTHERAPEUTICS INC 8.5%

Value ($000) $23,927 Shares 1,891,467 Est. Cost $32.91 Unrealized —

— AKOUOS INC 7.4%

Value ($000) $20,829 Shares 1,794,088 Est. Cost $19.83 Unrealized —

— INOZYME PHARMA INC 6.5%

Value ($000) $18,441 Shares 1,591,154 Est. Cost $20.64 Unrealized —

— ALIGOS THERAPEUTICS INC 4.8%

Value ($000) $13,595 Shares 876,548 Est. Cost $27.65 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 4.8%

Value ($000) $13,594 Shares 569,041 Est. Cost $24.49 Unrealized -6.9%

— FUSION PHARMACEUTICALS INC 4.5%

Value ($000) $12,659 Shares 1,598,379 Est. Cost $11.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	KARUNA THERAPEUTICS INC	852,708	$104,312	36.9%	$101.59	—	COM	48576A100
—	RALLYBIO CORP	2,271,311	$39,930	14.1%	$17.58	—	COM	75120L100
PCVX	VAXCYTE INC	1,405,421	$35,656	12.6%	$37.18	-34.8%	COM	92243G108
—	BOLT BIOTHERAPEUTICS INC	1,891,467	$23,927	8.5%	$32.91	—	COM	097702104
—	AKOUOS INC	1,794,088	$20,829	7.4%	$19.83	—	COM	00973J101
—	INOZYME PHARMA INC	1,591,154	$18,441	6.5%	$20.64	—	COM	45790W108
—	ALIGOS THERAPEUTICS INC	876,548	$13,595	4.8%	$27.65	—	COM	01626L105
ARQT	ARCUTIS BIOTHERAPEUTICS INC	569,041	$13,594	4.8%	$24.49	-6.9%	COM	03969K108
—	FUSION PHARMACEUTICALS INC	1,598,379	$12,659	4.5%	$11.75	—	COM	36118A100